FDA Approves 23andMe's DNA Test, But Not the One It Halted Earlier
FDA's decision to approve 23andMe's Bloom syndrome carrier test is a first step for the online offer of medical genetic testing, but the real regulatory breakthroughs have yet to come.
Cecile Janssens, ContributorProfessor of translational epidemiology at Emory University